‘Repurposed Drugs in Metabolic Disorders’
Author(s): Josef Finsterer and Marlies Frank
Abstract: Drug repurposing (drug repositioning, drug reprofiling, drug retasking) gains increasing importance as the development of new drugs becomes increasingly expensive. Though only a few compounds have been approved for new indications in the field of metabolic disorders, there are a number of substances which have the potential to become reprofiled in a new indication. Generally, reprofiled drugs for metabolic disorders can be classified in three groups. Group A contains those of which both, the original and repurposed indication, concern metabolic disorders. Group B comprises drugs, which were originally approved for non-metabolic disorders but show beneficial effects for metabolic disorders after repurposing..
Download the complete article from here: http://www.eurekaselect.com/node/115624/article
This article is from the journal Current Topics in Medicinal Chemistry
Bentham Science 